NEERVANA Trademark

Trademark Overview


On Wednesday, December 30, 2020, a trademark application was filed for NEERVANA with the United States Patent and Trademark Office. The USPTO has given the NEERVANA trademark a serial number of 90431304. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Wednesday, October 13, 2021. This trademark is owned by Visus Therapeutics Inc.. The NEERVANA trademark is filed in the Pharmaceutical Products category with the following description:

Ophthalmic drugs
neervana

General Information


Serial Number90431304
Word MarkNEERVANA
Filing DateWednesday, December 30, 2020
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateWednesday, October 13, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 15, 2021

Trademark Statements


Goods and ServicesOphthalmic drugs

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateWednesday, October 13, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVisus Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109

Party NameVisus Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109

Trademark Events


Event DateEvent Description
Wednesday, October 13, 2021ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Wednesday, October 13, 2021ABANDONMENT - AFTER PUBLICATION
Thursday, October 7, 2021TEAS EXPRESS ABANDONMENT RECEIVED
Thursday, July 1, 2021EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, June 15, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 15, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 11, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 3, 2021ASSIGNED TO EXAMINER
Wednesday, March 24, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, January 2, 2021NEW APPLICATION ENTERED IN TRAM

Related Keywords


neervana drugs ophthalmic